Please Wait
Applying Filters...
menu
    • menu
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Chiauranib

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Phase III Trial for Chiauranib in Small Cell Lung Cancer Approved
    Phase III Trial for Chiauranib in Small Cell Lung Cancer Approved

    01 Nov 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/the-phase-iii-clinical-trial-application-for-first-line-treatment-of-extensive-disease-small-cell-lung-cancer-with-chiauranib-has-been-approved-302294039.html

    PR NEWSWIRE
    01 Nov 2024
    Share Share
    Chiauranib, an Anti-tumor Drug Developed by Chipscreen, is Given CDE
    Chiauranib, an Anti-tumor Drug Developed by Chipscreen, is Given CDE

    04 Jan 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/chiauranib-an-anti-tumor-drug-developed-by-chipscreen-is-given-cde-breakthrough-therapy-designation-301200869.html

    PRNEWSWIRE
    04 Jan 2021
    Share Share